Arlesheim, Switzerland

Hans-Ulrich Naegeli

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Novartis Ag. Active years: 1998-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans-Ulrich Naegeli. Retrieved from https://idiyas.com/inventor/hans-ulrich-naegeli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7


Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Arlesheim, CH (1998 - 2000)
  • Basel, CH (2012)

Company Filing History:


Years Active: 1998-2012

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Hans-Ulrich Naegeli

Introduction

Hans-Ulrich Naegeli is a prominent inventor based in Arlesheim, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial compounds. With a total of 3 patents to his name, Naegeli's work has had a notable impact on medical science.

Latest Patents

One of his latest patents focuses on antibacterial compounds and processes for their production. This invention relates to novel antibiotic compounds, pharmaceutically acceptable salts, and derivatives thereof, along with methods for obtaining such compounds. Additionally, he has worked on organic compounds that further enhance the pharmaceutical landscape.

Career Highlights

Hans-Ulrich Naegeli is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Some of his notable coworkers include Michael Morris Dreyfuss and Carolyn Ann Foster. Their combined expertise has fostered an environment of innovation and creativity within their projects.

Conclusion

Hans-Ulrich Naegeli's contributions to the field of pharmaceuticals through his patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new medical treatments and compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…